INTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEAR
Ambu posts 4% organic revenue growth for the second quarter of 2022/23, in line with expectations. The quarter was driven by continued strong growth in urology and ENT, offset by pulmonology and... | May 3, 2023